This trial is testing a new intervention to help people with substance use disorder by targeting brain biomarkers that make relapse more likely.
1 Primary · 0 Secondary · Reporting Duration: 2 months
Experimental Treatment
Non-Treatment Group
80 Total Participants · 2 Treatment Groups
Primary Treatment: tDCS · Has Placebo Group · N/A
Age 18 - 65 · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: